Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

LY-3372689, a novel OGA enzyme inhibitor for the treatment of Alzheimer's disease

April 4, 2022

SBT-272 shows behavioral and metabolic improvements in mouse model of Huntington's disease

March 31, 2022

AC-0027136 improves memory impairment and mitochondrial function

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Orexia Therapeutics discovers orexin OX2 receptor agonists

March 31, 2022

Researchers present new Slc39a14-knockout dystonia murine model

March 30, 2022

Protein is marker, target for diabetic neuropathy

March 30, 2022

Alpha Cognition reports in vivo and in vitro data on ALPHA-0602 for ALS

March 30, 2022

Novel ferroptosis inhibitor mitigates cerebral ischemic injury in rat

March 30, 2022

Cybin completes in vivo studies for deuterated psilocybin analogue CYB-003 for MDD

March 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...